FCGR3B eiwit (C-AVI & zijn, mens)

FCGR3B

CD16, CD16-I, CD16A, CD16b, FCG3, FcgammaRIIIb, FCGR3, FCGR3A, FCR-10, FCRIII, FCRIIIb, IGFR3

C-AVI & His

< 1.0 EU per μg protein as determined by the LAL method.

≥ 95 % as determined by SDS-PAGE, ≥ 90 % as determined by SEC-HPLC, ≥ 90% as determined by SEC-MALS (Routinely tested) .

1.Loaded Recombinant Human CD16B Protein (NA1 allotype, AVI & His Tag), Biotinylated (Cat: 11046-H27H1-B) on SA Biosensor, can bind anti-CD20 (Research grade Rituximab Biosimilar) with an affinity constant of 4.3 μM as determined in BLI assay (Sartorius Octet RED384) (QC tested) . 2.Recombinant Human CD16B Protein (NA1 allotype, AVI & His Tag), Biotinylated (Cat: 11046-H27H1-B) immobilized on SA chip, can bind anti-ERBB2 (Research grade trastuz*mab biosimilar) with an affinity constant of 3.620 μM as determined in an SPR assay (Biacore 8K) (Routinely tested) .

Met1-Ser200

The recombinant human FCGR3B consists of 207 amino acids and predicts a molecular mass of 23.75 kDa. As a result of glycosylation, it migrates as an approximately 44.02 kDa band in SDS-PAGE under reducing conditions. The molecular weight of this protein is around 26-44 kDa verified by SEC-MALS (Routinely tested) .

Human